To circumvent this dilemma, we chose an experimentally robust cervical cancer cell line (HeLa), which has a comparable expression of CREB1 to many CREB1 sensitive cancer cell lines, to generate the CREB1 KO cells. Here, CREB1 is linked to cervical cancer.